SCHEMBL30132886

SCHEMBL30132886

CC(C)(C)OC(=O)N1CCOc2cc(N)ccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 2/20 0.50
NR1H2 P55055 1/20 0.46
NOTUM Q6P988 1/20 0.42
KDM1A O60341 1/20 0.40
EGFR P00533 1/20 0.40
BTK Q06187 1/20 0.40
CSNK2A1 P68400 2/20 0.39
CSNK2A2 P19784 1/20 0.39
KDR P35968 1/20 0.37
MPO P05164 1/20 0.37
USP2 O75604 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
DGAT1 O75907 1/20 0.36
MAPT P10636 3/20 0.36
MEN1 O00255 2/20 0.36
THRB P10828 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALOX15 P16050 1/20 0.36
GFER P55789 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2825274 1.00 USP30 (0.50) USP30NR1H2NOTUMKDM1AEGFR
SCHEMBL2363147 0.90 NR1H2 (0.46) USP30NR1H2NOTUMKDM1AEGFR
SCHEMBL3897500 0.86 USP30 (0.51) USP30NOTUMKDM1AEGFRBTK
SCHEMBL26429611 0.86 USP30 (0.51) USP30NOTUMKDRMAPTMEN1
SCHEMBL8131708 0.85 MAPT (0.45) USP30NOTUMKDRMAPTMEN1
SCHEMBL5276056 0.85 USP30 (0.50) USP30NOTUMKDM1AEGFRBTK
SCHEMBL26092853 0.82 USP30 (0.48) USP30NOTUMKDM1AEGFRBTK
SCHEMBL30419049 0.82 USP30 (0.48) USP30NOTUMKDM1AEGFRBTK
SCHEMBL26429621 0.81 HDAC1 (0.50) USP30NOTUMEGFRBTKCSNK2A1
SCHEMBL29628537 0.81 NOTUM (0.64) USP30NOTUMKDM1AMAPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025201477-A1 SPIROCYCLIC GSDME INHIBITORS PYROTECH (BEIJING) BIOTECHNOLOGY CO.,LTD. (CN) 2025-10-02 WO disclosed
US-20230148299-A1 FEM1B PROTEIN BINDING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-05-11 US disclosed
EP-4117640-A1 FEM1B PROTEIN BINDING AGENTS AND USES THEREOF The Regents of the University of California (US) 2023-01-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230148299-A1 FEM1B PROTEIN BINDING AGENTS AND USES THEREOF FEM1B, GSKIP, FNIP1 USP30 1756/4885NR1H2 2284/4885NOTUM 4098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.